Beta-catenin-related anomalies in apoptosis-resistant and hormone-refractory prostate cancer cells

Clicks: 380
ID: 268414
2003
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Popular

Ranked #5 of 11 articles by views in clinical cancer research : an official journal of the american association for cancer research

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
These data suggest that anomalies of beta-catenin expression occur in PrCa and that these anomalies are associated with disease progression, especially to the therapeutic-resistant state.
Reference Key
a2003clinicalbeta-catenin-related Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors de la Taille A;Rubin MA;Chen MW;Vacherot F;de Medina SG;Burchardt M;Buttyan R;Chopin D;;
Journal clinical cancer research : an official journal of the american association for cancer research
Year 2003
DOI
DOI not found
URL
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.